From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Three Brains Bailey, Me and Now Berenberg Reckon Johnson Matthey's Share Price is Too Low. That May Not Last

By Malcolm Stacey | Monday 7 June 2021


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Hello, Share Seekers. For some reason which escapes me Johnson Matthey (JMAT), the chemicals giant, has seen a falling share price while other Footsie members have (slowly) been crawling forwards. And yet this is one of those British giants that should grow strongly into the brave new world of progressing technology. Never mind, in the last few days, the share price has rallied and I expect it to do even better within the next few months.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 11:39:55